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ABSTRACT
In adults, hematopoiesis occurs in bone marrow (BM) through a complex process with differentiation of hematopoietic 
stem cells (HSCs) to immune and blood cells. Human HSCs and their progenitors express CD34. Methods on 
hematopoietic regulation are presented to show the effects of the chemokine, stromal-derived growth factor (SDF)-1a 
and the neuropeptide, substance P (SP). SDF-1a production in BM stroma causes interactions with HSCs, thereby 
retaining the HSCs in regions close to the endosteum, at low oxygen. Small changes in SDF-1a levels stimulate HSC 
functions through direct and indirect mechanisms. The indirect method occurs by SP production, which stimulates 
CD34
+ cells, supported by ligand-binding studies, long-term culture-initiating cell assays for HSC functions, and 
clonogenic assays for myeloid progenitors. These methods can be applied to study other hematopoietic regulators. 
INTRODUCTION
Hematopoiesis is the process by which hematopoietic 
stem cells (HSCs) self-renew to form blood and immune 
cells of the body. In the healthy adult, the major site of 
hematopoiesis   is   the   bone   marrow   (BM)   (1,2).   HSCs 
differentiate into common myeloid progenitor (CMP) or 
common lymphoid progenitor (CLP).  CMLs differentiate 
into   multiple   lineages   to   produce   erythrocytes, 
monocytes,   megakaryocytes,   dendritic   cells   and 
granulocytes (3). CLPs generate lymphoid cells, T- and B 
cells,   natural   killer   cells   and   dendritic   cells   (4,5).   In 
contrast,   dysfunctional   BM   shows   extra-medullary 
hematopoiesis, such as in spleen (6). HSCs are mainly 
found in areas closest to the endosteum of BM in the 
region of lowest oxygen level (7). The BM is also host to 
another stem cell, mesenchymal stem cells (MSCs), which 
is located surrounding blood vessels and in contact with 
trabeculae (8). MSCs are functionally linked to HSCs since 
the supporting stromal cells for the latter are generated 
from MSCs (9,10).
Hematopoiesis   is   regulated   by   a   complex   system 
involving soluble factors such as cytokines, chemokines, 
neuropeptides and neurotransmitters (11). Extracellular 
matrix proteins (ECM) are also involved in hematopoietic 
regulation and are not mutually exclusive of cytokines 
(11,12).   There   is   no   direct   link   between   families   of 
regulator with functions since the BM microenvironment 
could   influence   hematopoietic   outcome   (11,12).   Thus, 
hematopoietic   regulators   involve   a   complex   network 
involving cellular interactions in a network of soluble 
factors and ECM. This study focuses on a method to study 
two regulators of hematopoiesis, stromal-derived growth 
factor (SDF)-1a  and the preprotachykinin I gene, also 
referred   to   as  Tac1.   SDF-1a  belongs   to   the   CXC 
chemokines   family,   and   interacts   with   the   CXCR-4 
receptor that belongs to the family of G-protein, seven 
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transmembrane receptors (13). SDF-1a is produced by BM 
stromal cells and could be released or membrane-bound 
(14,15). CXCR4 receptors are expressed on HSCs, making 
them poised to form complexes with stromal cells through 
interactions   with   membrane-bound   SDF-1a  (14,15). 
Disruption of the SDF-1a-CXCR4 complex could cause 
mobilization of HSCs from BM into the periphery (14). 
SDF-1a levels show a pattern of gradient changes across 
the BM (16). Gradient changes in SDF-1a across the BM 
facilitate mobilization of HSCs in and out of the BM (14). 
In addition to its mobilization role, SDF-1a has a major 
role in hematopoiesis at all levels of maturity within the 
hematopoietic lineages (17,18). 
Tac1 encodes peptides belonging to the tachykinin family 
of peptides (19). Tachykinins’  presence in BM could be 
from the innervation in BM as neurotransmitters and from 
endogenous sources (20,21). The major Tac1 peptides are 
substance P (SP) and neurokinin-A (NK-A) (22). Substance 
P induces the production of cytokines with stimulatory 
effects on hematopoiesis whereas neurokinin-A acts in 
opposing   manner   (Table   1).   SP   and   NK-A  bind   the 
neurokinin (NK) receptors with varying affinities (23). 
Three NK receptors have been described, NK1-NK3 (24). 
This family of receptors belongs to the 7-transmembrane 
G-protein   coupled   receptor   family   (25).   SP   shows 
preference for NK1 and NKA demonstrates high affinity 
binding to NK2 (23). NK receptors are expressed on 
hematopoietic   progenitors   and   differentiated   immune 
cells (20). The hematopoietic effects mediated by NK1 and 
NK2 are confounded by crosstalk between these receptors, 
and fragments of Tac1 peptides that bind NK1 (22).
We have reported Tac1 expression by SDF-1a in the BM 
stroma   (19).   This   production   was   important   in   SP-
mediated effects on hematopoiesis (19). The hematopoietic 
effects  were examined  as  the  levels of  primitive  and 
mature hematopoietic progenitors by long-term culture-
initiating cell assay and clonogenic assay (19). Here we 
describe detailed methods to investigate hematopoiesis 
through secondary regulators and the incorporation of 
stromal cells.
MATERIALS AND METHODS
Reagents and cytokines
α-Minimum   Essential   Medium   (α-MEM),   glutamine, 
hydrocortisone, SP, and phthalic acid dially ester were 
purchased from Sigma (St. Louis, MO). Fetal calf sera 
(FCS) and horse sera (HS) were purchased from Hyclone 
Laboratories (Logan, UT). Recombinant human SDF-1a 
was purchased from R&D Systems, prolyl-4-hydroxylase 
mAb   from   Dako   Cytomation,   PE-anti-CD14   from   BD 
Pharmingen.     Recombinant   human   granulocyte 
macrophage colony-stimulating factor (rhGM-CSF) was 
provided by the Immunology Department of Genetics 
Institute (Cambridge, MA).  
125I-Tyr
8-SP (2200 Ci/mmol/L) 
was   purchased   from   Perkin   Elmer   (Billerica,   MA). 
Dimethyl phthalate was purchased from Fisher Scientific, 
Pittsburgh, PA.   Dynabead M-450 CD34 was purchased 
from DynaI Inc. (Lake Success, NY). PE-anti-CD34 was 
purchased from Becton Dickinson, San Jose, CA and Tri-
color-anti-CD45 from Caltag Laboratories (Burlingame, 
CA). 
Primary bone marrow cells
BM aspirates were obtained from the posterior iliac crest 
of healthy volunteers following the guidelines made by 
the   Institutional   Review   Board   of   the   University   of 
Medicine and Dentistry of New Jersey (Newark, NJ).  BM 
aspirates were obtained from healthy donors between the 
ages of 18-25 years.
Clonogenic assays for granulocyte-macrophage colony-
forming units (CFU-GM)
Mononuclear   cells   (BMNCs)   were   isolated   from   BM 
aspirates by Ficoll-Hypaque density gradient and then 
assayed for CFU-GMs in sera free culture as described 
(26).     105   mononuclear   cells/ml   were   plated   in 
methylcellulose with different concentrations of Substance 
P (SP) and 3 U/mL rhGM-CSF. Colonies with more >20 
cells were counted at day 10. 
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Preparation of BM Stroma
107 nucleated cells from BM Aspirates were added to 25 
cm
2 tissue culture flasks (Falcon 3109) in stromal media 
(a-MEM with 20% FCS) and incubated at 37°C for 3 days. 
Mononuclear cells were then separated by Ficoll-Hypaque 
density gradient and replated in fresh stromal medium. 
Cells   were   incubated   until   confluency   with   weekly 
replacement of 50% stromal medium.  At confluency, the 
trypsin-sensitive adherent cells were passaged at least 5 
times before being used for experiments.  Flow Cytometry 
studies indicated stromal cells were negative for CD14 
and positive for prolyl 4-hydroxylase.
Modified long-term culture-initiating cell (LTC-IC) culture
LTC-IC assays were performed as described (19). Stromal 
cells were cultured in 25-cm
2  flasks and at confluence, 
were  g-irradiated with 150 Gy delivered by a cesium 
source.  After 16 h, media were replaced with 5 ml of fresh 
media containing 107 BMNCs/flask. At weekly intervals, 
50% of culture media were replaced. The non-adherent 
cells were studied at various intervals in clonogenic assays 
for CFU-GM, described above.
Isolation of CD34
+ BM cells 
CD34
+ cells were positively selected from BMNC with an 
isolation kit (Dynabeads M-450 CD34) purchased from 
DynaI Inc. (Lake Success, NY) with a 2-step method as 
described.     BMNC (10
7-10
8) were washed  twice and 
resuspended in 1 ml of cold isolation buffer (Ca
2+/Mg
2+ - 
free PBS with 2% BSA).  10
8 Dynabeads M-450 CD34 were 
incubated with the cell suspension at 4°C for 30 min using 
gentle agitation at 5 min-intervals. Dynabeads were then 
magnetically selected with Dyna1 MPC and then washed 
(3x) with isolation buffer. Cells were uncoupled from the 
magnetic beads by incubating at  37°C  for 15 min with 
equal volumes of isolation buffer and DETACHaBEAD 
CD34   liquid.     Cells   were   double   labeled   with   PE-
conjugated anti-CD34 and Tri-color-conjugated anti-CD45. 
The process was repeated and the final population was 
>90% positive for CD34 and CD45. Since endothelial cells 
also express CD34, the inclusion of this cell subset in the 
selected cell population was determined using anti-von 
Willebrand Factor.   Less than 1% of selected cells were 
positive for vWF.      
Binding Assay
Varying   concentrations   (3-200   mmol/L)   of  
125I-Tyr
8-SP 
(2200 Ci/mmol/L) were added to 1ml of CD34
+ cells and 
resuspended at 10
6/mL.  Tubes were rotated at 4°C with a 
Rotating   Wheel   Two-way   Mixer   (Robbins   Scientific, 
Sunnyvale, CA) for 4 hours in order to allow for binding. 
After this period of incubation, cells were layered in 
siliconized microcentrifuge tubes on 0.5 mL phthalate oils 
(90 parts dimethyl phthalate and 10 parts phthalic acid 
dially ester) and then centrifuged at 10,000 g for 1 min at 
4°C.  The cells were incubated for 4 h, which falls within 
the range required for equilibrium that was established in 
time course binding assays ranging from 1 to 12 h. The 
radioactivity was measured in the pellet and supernatant 
fractions in order to determine the amount of bound and 
unbound   ligand,   respectively.   Radioactivity   was 
determined using the Beckman gamma counter (Beckman 
Instruments,   Irvine,   CA).     Triplicate   binding   were 
performed for each donor and concentration of ligand. 
The McPherson's modification of the Radioligand Binding 
Analysis software was used to analyze the data.
Results and Discussion
The role of Tac1 peptides as mediators within the neural-
immune-hematopoietic   axis   has   been   widely   studied 
(20,21).The   hematopoietic   effects   of  SP  and   NKA  are 
mostly mediated through their interaction with NK1 and 
NK2, respectively (27,28). However, the effects of these 
peptides are not only direct, but indirectly through the 
production   of   cytokines   and   other   hematopoietic 
regulations in BM resident cells (Table 1).
Experimentally, studies can be done to show effects of 
Tac1 peptides on hematopoiesis, at an early stage by LTC-
IC assays (27-33). In addition to the early phase, SP and 
NKA also affect hematopoietic progenitors at the myeloid 
level, which was studied by clonogenic assays for CFU-
GM (Table 1). The effects of tachykinins are not only 
mediated through cytokine production, but could also 
occur directly. This premise is based on the ability of SP to 
bind CD34
+ BM cells at dissociation constant of 70 nM/L 
on a cell subset that includes both early and late human 
progenitors   (Fig.   1).The   methods   described   in   this 
technique paper could be applied in studies to investigate 
the roles of cytokines in the network developed by Tac1 in 
BM stromal cells.
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Fig. 2 summarizes how the methods could be applied to 
study the effects of SDF-1a on Tac1 expression, and the 
consequence to hematopoiesis. SDF-1a  is expressed as 
baseline in stromal cells. Upon stimulation by exogenous 
SDF-1a, which could be produced by other accessory 
cells, and also by stroma, Tac1 expression is upregulated. 
This could lead to the production of SP, which could 
mediate direct stimulation on HSCs (Fig. 1), or indirectly 
by inducing the production of other cytokines in cells 
within   BM   microenvironment.   These   cytokines   could 
stimulate hematopoiesis. To address questions similar to 
the network described in Fig. 2, experimental studies 
could be developed by clonogenic assays, LTC-IC assays 
and  cytokine quantitation and mechanistic studies on 
cause-effect relationship could be done by knockdown 
and expression approaches (19).The effects of SP on the 
stimulation of primitive HSCs and progenitors have been 
attributed   to   the   induction   of   specific   hematopoietic 
growth factors including IL-3, IL-6, GM-CSF, SCF, flt3/flk2 
(29). Similarly, NK-A, induces the production of specific 
cytokines with hematopoietic suppressive effects (30). We 
have reported the production of TGF-b  and MIP-1a by 
NK-A in stromal cells (30). Together, the positive and 
negative   effects   of   the   tachykinins   lead   to   an 
understanding of hematopoietic homeostasis. 
Table 1: Correlations between Tac1 peptide-mediated hematopoietic 
effects and cytokine production. 
Tachykinins Hematopoietic 
effects
Hematopoietic 
regulators
Reference
Neurokinin 
A (NKA)
↓ Suppressive  31
Substance P 
(SP)
↑ Broad-
acting; 
Stimulatory
32
:  Decrease hematopoietic activity ↓
:  Increase hematopoietic activity ↑
The general hematopoietic effects of the two major Tac1 
peptides, substance P and neurokinin-A. Each peptide 
induces  the  production  of specific cytokines in BM-
resident   cells.   The   cytokines   correlates   with 
hematopoietic effects mediated by the peptide.
Fig. 1: Scatchard analysis of SP-binding sites on CD34
+ cells. We 
performed ligand-binding studies with 
125I-Tyr-SP to confirm SP is capable 
of binding to CD34
+ cells and also to determine the binding kinetics of SP 
on these cells.
Additionally,   SDF-1a  is   shown   to   be   involved   in 
hematopoiesis (19).   In BM, SDF-1a  follows a gradient 
pattern   with   the   highest   levels   close   to   the   stromal 
compartment (32). CXCR4, expressed on HSCs mediates 
retention in BM (32). Changes in SDF-1a  in BM could 
cause   increased   hematopoietic   activity   and   also 
mobilization of HSCs. The molecules involved in this 
process could be identified using the methods described 
as the basis for questions.
Fig. 2: The effects of SP, NK-A and SDF-1a on hematopoiesis. BM stroma 
is innervated by peptidergic fibers, which can release two neuropeptides, 
SP and NK-A.  SP interacts with BM Stroma via a specific receptor, NK1, 
which induces growth factors that stimulate hematopoiesis.  NKA can also 
be produced by peptidergic fibers, which interact with NK2 on BM Stroma, 
which causes inhibition of hematopoiesis. High levels of SDF-1a stimulate 
BM Stroma to induced SP production, which stimulates hematopoiesis.
Patel et al. – An in vitro method to study the effects of hematopoietic regulators during immune and blood cell development
www.biologicalprocedures.com60
ACKNOWLEDGMENTS
This   work   was   supported   by   grant   awarded   by   the 
Department   of   Defense   and   UH-New   Jersey   Medical 
School Cancer Center.
REFERENCES
1. Zon   LI.   Developmental   biology   of   hematopoiesis. 
Blood 1995;86:2876-2891.
2. Weissman IL. Stem Cells: units of development, units 
of   regeneration,   and   units   of   evolution.  Cell 
2000;100:157-168.
3. Moore KA, Ema H, Lemischka IR. In vitro maintenance 
of highly purified, transplantable hematopoietic stem 
cells. Blood 1997;89:4337-4347.
4. Manz   MG,   Traver   D,   Miyamoto   T,   Weissman   IL, 
Akashi K. Dendritic cell potentials of early lymphoid 
and myeloid progenitors. Blood 2001;97:3333-3341.
5. Morrison   SJ,   Shah   NM,   Anderson   DJ.   Regulatory 
mechanisms in stem cell biology. Cell 1997;88:287-298.
6. Rameshwar P, Oh HS, Yook C, Gascon P, Chang VT. 
Substance   P-Fibronectin-Cytokine   Interactions   in 
Myeloproliferative   Disorders   with   Bone   Marrow 
Fibrosis. Acta Haematologica 2003;109:1-10.
7. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The 
sympathetic nerve – an intergrative interface between 
two supersystems: the brain and the immune system. 
Pharmacol Rev 2000;52:595-638.
8. Deans   RJ,   Moseley   AB.   Mesenchymal   stem   cells: 
biology   and   potential   clinical   uses.  Exp   Hematol 
2000;28:875-884.
9. Arai F, Ohneda O, Miyamoto T, Zhang XQ, Suda T. 
Mesenchymal   stem   cells   in   perichondrium   express 
activated   leukocyte   cell   adhesion   molecule   and 
participate in bone marrow formation.  J Exp Med 
2002;195:1549-1563.
10. Caplan   AI,   Bruder   SP.   Mesenchymal   stem   cells: 
building  blocks  for  molecular  medicine  in  the  21
st 
century. Trends Mol Med 2001;7:259-264.
11. Kaushansky  K,  Karplus AP.  Hematopoietic growth 
factors:   Understanding   functional   diversity   in 
structural terms. Blood 1993;82:3229-3240.
12. Muller-Sieburg CE, Deryugina E. The stromal cells’ 
guide   to   the   stem   cell   universe.  Stem   Cells 
1995;13:477-486.
13. Claps CM, Corcoran KE, Cho KJ. Stromal derived 
growth factor-1alpha as a beacon for stem cell homing 
in   development   and   injury.  Curr   Neurovasc   Res 
2005;2:319-329.
14. Lapidot T, Dar A, Kollet O. How do stem cells find 
their way home? Blood 2005;106: 1901-1910.
15. Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski 
W, Janowska-Wieczoreck A, Ratajczak J, Ratajczak MZ. 
Trafficking  of normal stem cells and metastasis of 
cancer stem cells involve similar mechanisms: pivotal 
role   of   the   SDF-1-CXCR4   axis.  Stem   Cells  2005;7: 
879-894.
16. Laurence AD. Location, movement and survival: the 
role of chemokines in haematopoiesis and malignancy. 
Br J Haematol 2006;132:255-267.
17. Arai A, Jin A, Yan W, Mizuchi D, Yamamoto K, Nanki 
T,   Miura   O.   SDF-1   synergistically   enhances   IL-3-
induced   activation   of   the   Raf-1/MEK/Erk   signaling 
pathway through activation of Rac and its effector Pak 
kinases to promote hematopoiesis and chemotaxis. Cell 
Signaling 2005;17:497-506.
18. Moharita AL, Taborga M, Corcoran KE, Bryan M, Patel 
SP, Rameshwar P. SDF-1a regulation in breast cancer 
cells contacting bone marrow stroma is critical for 
normal hematopoiesis. Blood 2006;108:3245-3252.
19. Corcoran KE, Patel N, Rameshwar P. Stromal Derived 
Growth   Factor-1a:   Another   Mediator   in   Neural-
Emerging Immune System through Tac1 Expression in 
Bone   Marrow   Stromal   Cells.  J   Immunol 
2007;178:2075-2082.
20. Greco   S,   Corcoran   KE,   Cho   KJ,   Rameshwar   P. 
Tachykinins   in   the   emerging   immune   system: 
relevance   to   bone   marrow   homeostasis   and 
maintenance   of   hematopoietic   stem   cells.  Frontiers 
Biosci 2004;9:1782-1793.
21. Rameshwar P, Gascon P. Hematopoietic Modulation by 
the Tachykinins. Acta Haematol 1997;98:59-64.
22. Kang   HS,   Trzaska   K,   Corcoran   KE,   Chang   VT, 
Rameshwar P. Neurokinin receptors: relevance to the 
emerging immune system.  Arch Immunol. Ther. Exp 
2004;52:338-347.
23. Quartara L, Maggi CA. The tachykinin NK1 receptor: 
Part   II.   Distribution   and   pathophysiological   roles. 
Neuropepides 1998;32:1-49.
24. Gerard NP, Bao L, Ping HX, Gerard C. Molecular 
aspects of the tachykinin receptors.  Regul Peptides 
1993;43:21-35.
25. Patacchini R, Maggi CA. Tachykinin receptors and 
receptor   subtypes.  Arch   Int  Pharmacaodyn 
1995;329:161-184.
26. Maloof PB, Joshi DD, Qian J, Gascon P, Singh D, 
Rameshwar   P.   Induction  of  preprotachykinin-I  and 
Patel et al. – An in vitro method to study the effects of hematopoietic regulators during immune and blood cell development
www.biologicalprocedures.com61
neurokinin-1   by   adrenocorticotropin   and   prolactin. 
Implication   for   neuroendocrine-   immune-
hematopoietic axis. J Neuroimmunol 2001;112:188-196.
27. Joshi DD, Dang A, Yadav J, Qian J, Bandari PS, Chen 
K,   Donnelly   R,   Castro   T,   Gascon   P,   Haider   A, 
Rameshwar P. Negative feedback on the effects of stem 
cell factor on hematopoiesis is partly mediated through 
endopeptides   activity   on   substance   P:   a   combined 
functional   and   proteomic   study.  Blood  2001;98: 
2697-2706.
28. Rameshwar   P,   Gascon   P.   Neural   regulation   of 
hematopoiesis   by   the   tachykinins.  Mol   Biol 
Hematopoiesis 1996;5:463-470.
29. Rameshwar   P,   Gascon   P.   Induction   of   negative 
hematopoietic   regulators   by   neurokinin-A  in   bone 
marrow stroma. Blood 1996;88:98-106.
30. Gascon   P,   Qian   J,   Joshi   DD,   Teli   T,   Haider   A, 
Rameshwar   P.   Effects   of   PPT-1   Peptides   on 
hematopoietic homeostasis. A role for bone marrow 
endopeptidases. Ann NY Acad Sci 2000;917:416-423. 
31. Rameshwar P, Poddar A, Gascon P. Hematopoietic 
regulation   medicated   by   interactions   among   the 
neurokinins   and   cytokines.  Leuk   Lymphoma 
1997;28:1-10.
32. Rameshwar P, Gascon P. Substance P mediates the 
production of stem cell factor and interleukin-1 in bone 
marrow stroma.  Blood 1995;88:98-106.
33. Rameshwar P, Ganea D, Gascon P. In vitro stimulatory 
effect   of   substance   P   on   hematopoiesis.    Blood 
1993;81:391-398.
Patel et al. – An in vitro method to study the effects of hematopoietic regulators during immune and blood cell development
www.biologicalprocedures.com62
PROTOCOLS
Perform all procedures under sterile conditions.
A. Stromal Isolation, 2-step procedure:
Step 1:
1. Get approval for use of human tissues by the Institutional Review Board.
2. Obtain bone marrow (BM) aspirates from healthy donors. The aspirate is obtained in a syringe containing 
preservative-free heparin at 50 U/ml. The heparin is diluted in any tissue culture media containing 50 U/mL 
Penicillin and 0.05 mg/mL Streptomycin. 
3. Count the nucleated cells in the aspirates.
4. Add ~ 10
7 nucleated BM aspirate cells into a 25 cm
2 tissue culture flasks (Falcon 3109). Adjust total volume to 7 
ml of stroma-I media. Stroma-I Media:
• α-MEM containing 12.5% Fetal Bovine Serum, 12.5% Horse Sera, 0.1% μ
• Hydrocortisone, 0.1 μM 2-mercaptoethanol, and 1.6mM glutamine 
• Incubate flasks in a 37
oC incubator with 5% CO2.
5. At day 3, remove the non-adherent cells from the flasks and place in a conical tissue culture tube. Combine the 
cells of each donor. Wash residual red blood cells (RBCs) in the flasks with sera-free media and transfer to the 
tubes containing the non-adherent cells. The wash media should be at room temperature.
6. Avoid the tissue culture flasks to dry by quickly adding 6 mL stromal media. Return flasks to the culture 
incubator.
7. Centrifuge tubes containing the non-adherent cells at 500 g. If the total volume is ~50 ml, centrifuge for 20-30 
min. If 10-20 mL, centrifuge for 10-15 min.
8. Aspirate media.
9. Resuspend pellet in sera-free a-MEM. Determine the total volume to resuspend the cells using the following 
guide: Pellets from five flasks should be resuspended in 20 mL a-MEM. If the pellet is from more than five 
flasks, split the cell suspension in multiple 50 mL conical tissue culture tubes. 
10. Add equal volumes of Ficoll Hypaque to the bottom of each tube. Centrifuge tubes at room temperature for 
25-30 min at 500 g. 
11. Carefully remove tubes from centrifuge. Aspirate the top layer comprising the suspension media. The next 
layer of white represents the mononuclear fraction (BMNC). Using a Pasteur pipet aspirate the BMNC and 
transfer into a clean sterile conical tissue culture tube. This would require taking a small volume of Ficoll 
Hypaque. Resuspend the cells with 10-20 volumes of sera-free a-MEM.
12.  Centrifuge tubes at 500 g for 20-30 min at room temperature.
13. Aspirate the media. Resuspend the pellet in stroma-I media. The volume of media will depend on the total 
numbers of flasks from which the non-adherent cells were obtained. For example, if the starting numbers were 
3 flasks, add 3 mL of stromal media.
14.  Remove the tissue culture flasks from the incubator. 
15. Add 1 mL of cell suspension/flask.
16. Re-incubate flasks. Each week replace 50% of the culture media with fresh stromal media until confluence.
Step 2:
1. Trypsinize confluent stromal cells from step 1 by adding 1-2 mL of 0.05% Trypsin with 0.053 Na-EDTA to each 
flask. Incubate in a 37
oC-incubator for 5 min. Examine flasks with an inverted microscope. If the cells de-
adhered, collect the cells and place into a conical tissue culture tube containing a-MEM with 10% FCS. Pool 
cells from a particular donor. If the cells do not appear de-adhered, tap the flasks and re-examine the flasks. If 
the cells remain adherent, reincubated the flasks until the cells de-adhered.
2. Pellet cells by centrifuging at 500 g for 10-15 min. Collect trypsin-sensitive cells and place in a test tube 
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containing any type of tissue culture media containing 10% FCS.
3. Resuspend cells in Stroma-II media. Add 3 mL of media for cells obtained from each flask. Stroma II Media:  a-
MEM with 20% heat inactivated FCS. 
4. Add 1 ml of cell suspension to 25 cm
2 tissue culture flask. Adjust the volume to 7 ml with fresh Stroma-II 
media.
5. At cell confluence, repeat cells passages, #1-4 of Step 2. 
6. Repeat step 5 four times.
7. Confirm the purity of stromal cells by immunofluorescence using the following antibodies:
• Anti-CD14 (PE, FITC or any other fluorochrome), expected to be negative.
• Anti-fibroblasts (non-overlapping fluorochrome, i.e., different from the conjugate used for anti-CD14. For 
example, if anti-CD14 is conjugated to PE, anti-fibroblasts should be conjugated to any fluorochrome but 
PE, expected to be positive.
Immunofluorescence Stain:
1. Collect cells in a polypropylene test tube.
2. Spin cells 10 min at 150 rpm.
3. Resuspend cell pellet in 1X PBS to wash
4. Spin 10 min at 150 rpm
5. Aspirate PBS and repeat
6. Resuspend cell pellet in 1-2 mL PBS
7. Add 1
oAntibodies (CD14 and anti-fibroblast). The concentration will need to be titrated every time a new vial 
of antibody is purchased.
8. Incubate 1-2 h, shake every 10 min
9. Wash 2 times with 1X PBS
10. Add 300 μL PBS
11. Read on the Flow Cytometer
* If CD14 is positive, continue to passage cells since macrophages are insensitive to trypsinization. 
B. Clonogenic Assay:
1. Get approval for use of human tissues by the Institutional Review Board.
2. Obtain bone marrow (BM) aspirates from healthy donors. The aspirate is obtained in a syringe containing 
preservative-free heparin at 50 U/mL. The heparin is diluted in any tissue culture media containing 50 U/mL 
Penicillin and 0.05 mg/mL Streptomycin.
3.  Isolate the mononuclear fraction by Ficoll Hypaque density gradient with the aspirates, diluted 1:1 with sera-
free media.
4. Add 1 mL of ~ 10
5 nucleated BM aspirate cells in suspension in 35 mm Nunc suspension dishes.
5. Incubate one week at 37
oC.
6. Count colonies with >20 cells.
Preparation of Methylcellulose:
Note: do not use fresh methylcellulose.  Freeze at least 2 month prior to use, this 
helps the methylcellulose to dissolve.
• Materials
• Methylcellulose, 4000 centipose – Fisher Scientific (Cat# M-352)
• 2 L-Erlenmeyer flask
• Large magnetic stir bar (must be large enough to stir methylcellulose at semisolid phase)
• 1.5 L endotoxin-free double distilled water
• Autoclavable measuring cylinder 1L
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• Sodium bicarbonate solution (7.5%)
Autoclave:
• 12 g (1.2%) methylcellulose (weigh in beaker then cover with double layer of aluminum foil)
• Erlenmeyer flask with stir bar
• Measuring cylinder, covered with double layer of foil
• 1.5 liters of Endotoxin free double distilled water (Three  500 mL bottles)
(Autoclave dry and wet items separately)
Methylcellulose (1.2%):
• chill 1 500 mL bottle of water to 4
oC
• Prepare 2x Iscove’s Media (if Iscove’s is not available, use 2x α-MEM)
• Set up a stirring/hot plate under sterile hood.  Slowly pour methyl cellulose in 300 mL boiling distilled 
water.  Stir vigorously while pouring.
• Stir just under boiling until the mixture is homogenous.
• Add 200 mL cold distilled water
• Cool to room temperature.  Add 500 ml 2x Iscove’s (room temp) while stirring
• Add 26.7 mL sodium bicarbonate (7.5%)
• Continue stirring in the cold room for 48 h
• Aliquot in 50 mL tubes, store at -20
oC
• Thaw at 4
oC prior to use
Long-Term Culture-Initiating Cell (LTC-IC) Assay:
• Place isolated stroma (as described above) in culture dishes with stroma media.
• At confluence, α-irradiated the cells for 150 Gy.
• Leave overnight
• After 16 hours, replace media with 5ml of fresh medium containing 10
7 BM mononuclear cells.
• Add 200 mL cold distilled water
• Weekly replace 50% of culture medium
• At week 6 and 12, take 10
5 of the non-adherent cells for analyses in clonogenic assays for CFU-GM.
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